634 related articles for article (PubMed ID: 18294824)
21. Liquisolid technique as a new approach to sustain propranolol hydrochloride release from tablet matrices.
Javadzadeh Y; Musaalrezaei L; Nokhodchi A
Int J Pharm; 2008 Oct; 362(1-2):102-8. PubMed ID: 18647643
[TBL] [Abstract][Full Text] [Related]
22. Properties of heat-treated sorghum and maize meal and their prolamin proteins.
Emmambux MN; Taylor JR
J Agric Food Chem; 2009 Feb; 57(3):1045-50. PubMed ID: 19143536
[TBL] [Abstract][Full Text] [Related]
23. Optimization of drug release from compressed multi unit particle system (MUPS) using generalized regression neural network (GRNN).
Ivic B; Ibric S; Betz G; Zorica D
Arch Pharm Res; 2010 Jan; 33(1):103-13. PubMed ID: 20191351
[TBL] [Abstract][Full Text] [Related]
24. Carboxymethyl high amylose starch as excipient for controlled drug release: mechanistic study and the influence of degree of substitution.
Lemieux M; Gosselin P; Mateescu MA
Int J Pharm; 2009 Dec; 382(1-2):172-82. PubMed ID: 19716866
[TBL] [Abstract][Full Text] [Related]
25. Design of prolonged release tablets using new solid acrylic excipients for direct compression.
Villanova JC; Ayres E; Oréfice RL
Eur J Pharm Biopharm; 2011 Nov; 79(3):664-73. PubMed ID: 21827852
[TBL] [Abstract][Full Text] [Related]
26. Formulation development and in vitro evaluation of theophylline microcapsules.
Ahmad M; Akhtar N; Murtaza G; Hussain SW
Pak J Pharm Sci; 2012 Jan; 25(1):15-9. PubMed ID: 22186304
[TBL] [Abstract][Full Text] [Related]
27. pH-independent drug release of an extremely poorly soluble weakly acidic drug from multiparticulate extended release formulations.
Riis T; Bauer-Brandl A; Wagner T; Kranz H
Eur J Pharm Biopharm; 2007 Jan; 65(1):78-84. PubMed ID: 16919924
[TBL] [Abstract][Full Text] [Related]
28. Mechanical properties of excipients do not affect polymer matrix formation.
Chatterjee L; Rades T; Tucker IG
Int J Pharm; 2010 Jan; 384(1-2):87-92. PubMed ID: 19819317
[TBL] [Abstract][Full Text] [Related]
29. Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine.
Tanaka N; Imai K; Okimoto K; Ueda S; Tokunaga Y; Ohike A; Ibuki R; Higaki K; Kimura T
J Control Release; 2005 Nov; 108(2-3):386-95. PubMed ID: 16253377
[TBL] [Abstract][Full Text] [Related]
30. [Thermoplastic granulation as an alternative method for the preparation of hydrophilic-lipophilic oral matriix tablets].
Dvorácková K; Rabisková M; Masteiková R; Vocilková L
Ceska Slov Farm; 2007 Jun; 56(3):129-34. PubMed ID: 17867525
[TBL] [Abstract][Full Text] [Related]
31. Theophylline loaded gastroretentive floating tablets based on hydrophilic polymers: preparation and in vitro evaluation.
Khan F; Ibn Razzak SM; Khan ZR; Azad MA; Chowdhury JA; Reza S
Pak J Pharm Sci; 2009 Apr; 22(2):155-61. PubMed ID: 19339225
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of oleo-gum resin as directly compressible tablet excipient and release retardant.
Kumar P; Singh I
Acta Pol Pharm; 2010; 67(3):307-13. PubMed ID: 20524434
[TBL] [Abstract][Full Text] [Related]
33. Development of sustained release fast-disintegrating tablets using various polymer-coated ion-exchange resin complexes.
Jeong SH; Park K
Int J Pharm; 2008 Apr; 353(1-2):195-204. PubMed ID: 18164882
[TBL] [Abstract][Full Text] [Related]
34. Effect of hydrophilic natural gums in formulation of oral-controlled release matrix tablets of propranolol hydrochloride.
Rajesh KS; Venkataraju MP; Gowda DV
Pak J Pharm Sci; 2009 Apr; 22(2):211-9. PubMed ID: 19339235
[TBL] [Abstract][Full Text] [Related]
35. Sustained release of acetaminophen from heterogeneous matrix tablets: influence of polymer ratio, polymer loading, and co-active on drug release.
Ebube NK; Hikal AH; Wyandt CM; Beer DC; Miller LG; Jones AB
Pharm Dev Technol; 1997 May; 2(2):161-70. PubMed ID: 9552442
[TBL] [Abstract][Full Text] [Related]
36. Preparation and characterization of zein/chitosan complex for encapsulation of α-tocopherol, and its in vitro controlled release study.
Luo Y; Zhang B; Whent M; Yu LL; Wang Q
Colloids Surf B Biointerfaces; 2011 Jul; 85(2):145-52. PubMed ID: 21440424
[TBL] [Abstract][Full Text] [Related]
37. Use of xanthan and its binary blends with synthetic polymers to design controlled release formulations of buccoadhesive nystatin tablets.
Sakeer K; Al-Zein H; Hassan I; Martin GP; Nokhodchi A
Pharm Dev Technol; 2010; 15(4):360-8. PubMed ID: 19772376
[TBL] [Abstract][Full Text] [Related]
38. Formulation and evaluation of Ficus glomerata mucilage sustained release matrix tablets of gliclazide.
Kumar CS; Reddy-Budideti KK; Battula SP; Ayyavala CS
Pak J Pharm Sci; 2011 Jul; 24(3):399. PubMed ID: 21715275
[TBL] [Abstract][Full Text] [Related]
39. Drug release behaviour from methyl methacrylate-starch matrix tablets: effect of polymer moisture content.
Bravo-Osuna I; Ferrero C; Jiménez-Castellanos MR
Eur J Pharm Biopharm; 2008 May; 69(1):285-93. PubMed ID: 17997292
[TBL] [Abstract][Full Text] [Related]
40. Citric acid monohydrate as a release-modifying agent in melt extruded matrix tablets.
Schilling SU; Bruce CD; Shah NH; Malick AW; McGinity JW
Int J Pharm; 2008 Sep; 361(1-2):158-68. PubMed ID: 18582547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
